Skip to main content
Veterinary Medicines

NOBIVAC RABIA

Authorised
  • Rabies virus, strain Pasteur RIV, Inactivated

Product identification

Medicine name:
NOBIVAC RABIA
Active substance:
  • Rabies virus, strain Pasteur RIV, Inactivated
Target species:
  • Cattle
  • Sheep
  • Horse
  • Dog
  • Cat
  • Ferret
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain Pasteur RIV, Inactivated
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Dog
    • Cat
    • Ferret
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3229 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 24/04/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 24/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 24/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."